Fundamental Analysis of MiMedx Group Inc - Growth / Value Index
MDXG - Valuation Highlights
Valuation Analysis
Tsr Value Index - Very Poor Score of 12.50
Price to Book Ratio of 3219.87 suggesting that it is very expensive
Book Value in last 3 years is trending down
Valuation Key Ratios
Ratio | TTM | Latest FY | Yoy Change | MRQ |
---|---|---|---|---|
Price to Earning | 4972.92 | 262510 | 1096321 % | |
Price to Book | 3187.18 | 7977.38 | 67388.09 % | 7.51 |
Price to Sales | 904.28 | 3684.25 | 111947 % | |
Enterprise Value to EBITDA Multiple | 25.82 | 79876.16 | 254190 % |
MDXG - Profitability Highlights
Profitability Analysis
Piotroski F Score - Good Value of 7.0
Net profit has jumped from negative to positive
During the past twelve months, the company has given a strong Return On Equity of 80.48%
During the past twelve months, the company has given a strong Return On Asset of 29.27%
Annual Net Profit in last 3 years is trending up
EBITDA is continuously increasing for last 3 Years
Good Net Margin of 18.18% is achieved by the company
Very Low Dividend Yield of 0 %
In the last three years, the company has given poor Net Margin
In the last three years, the company has given poor Returns on Equity
In the last three years, the company has given poor Returns on Assets
Profitability Key Ratios
Ratio | TTM | Latest FY | Yoy Change | MRQ |
---|---|---|---|---|
Return On Equity | 80.48 | 3.04 | 0 % | 5.95 |
Return On Asset | 29.27 | 1.81 | 108.46 % | 4.18 |
Net Profit Margin | 18.18 | 1.40 | 110.22 % | 10.93 |
Operating Profit Margin | 13.29 | 4.78 | 151.22 % | 15.64 |
EBITDA Margin | 13.54 | 4.61 | 144.91 % | 16.53 |
Highlights
Market Cap | 1151.31 M |
Enterprise Value | 1118.96 M |
Price/Book TTM | 3187.18 |
Outstanding Share | 147604 K |
Float/ Outstanding Share | 79.71% |
Dividend Yield | 0 % |
Share Holding
Guru Numbers
Price/Graham No | 1327.84 |
Peter Lynch Ratio | 0 |
Piotroski F Score | 7.00 |
Altman Z Score | 8.42 |
Sloan Ratio | -0.0274 |
Peter Lynch Fair Value | 0.0392 |
MDXG - Growth Highlights
Growth Analysis
Steady increase in Total Assets for last 3 Years
Tsr Growth Index - Poor Score of 28.05
Growth Key Fields
Field | TTM | YoY Growth | QoQ Growth |
---|---|---|---|
Revenue | 320136 K | 15.37 % | 2.44 % |
Gross Profit | 279120 K | 15.64 % | 2.00 % |
EBITDA | 43333.00 K | 151.81 % | 9.62 % |
Net Profit | 58214.00 K | 111.79 % | 81.94 % |
EPS | 0.0016 | 100.01 % | NA |
MDXG - Stability Highlights
Stability Analysis
Altman Z Score of 8.50 suggests good Stability
Company financial liquidity has improved
Stability Key Ratios
Ratio | Latest FY | Yoy Change | MRQ |
---|---|---|---|
Debt to Equity Ratio | 0.348 | 112.51 % | 0.125 |
Cash Ratio | 1.78 | 17.71 % | |
Quick Ratio | 3.11 | 12.06 % | 2.71 |
Shareholders Equity | 59.70 | 668.98 % | |
Debt to EBITDA | 3.48 | 291.51 % |
Historical Valuation Ratios of MiMedx Group Inc
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of MiMedx Group Inc
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of MiMedx Group Inc
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of MiMedx Group Inc
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)